Skip to main content
. 2022 Sep 6;13:963638. doi: 10.3389/fphar.2022.963638

FIGURE 2.

FIGURE 2

Immunofluorescence staining. In comparison to the control group, proportion of CD8+/IFNγ+ cells, and CD49b+/CD107a+ cells in tumor tissues belonging to the CHMACS-treated group was significantly higher.